• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Towards a rational use of low-molecular-weight heparin in patients with cirrhosis.

作者信息

Lisman Ton, Porte Robert J

出版信息

Liver Int. 2011 Aug;31(7):1063. doi: 10.1111/j.1478-3231.2011.02489.x. Epub 2011 Feb 25.

DOI:10.1111/j.1478-3231.2011.02489.x
PMID:21733099
Abstract
摘要

相似文献

1
Towards a rational use of low-molecular-weight heparin in patients with cirrhosis.肝硬化患者合理使用低分子量肝素的探讨。
Liver Int. 2011 Aug;31(7):1063. doi: 10.1111/j.1478-3231.2011.02489.x. Epub 2011 Feb 25.
2
Dosing and monitoring of low-molecular-weight heparin in cirrhotic patients.肝硬化患者低分子量肝素的给药与监测
Liver Int. 2011 Aug;31(7):1064. doi: 10.1111/j.1478-3231.2011.02548.x. Epub 2011 May 31.
3
Anticoagulation in cirrhosis patients: what don't we know?肝硬化患者的抗凝治疗：我们还不知道什么？
Liver Int. 2011 Jan;31(1):4-6. doi: 10.1111/j.1478-3231.2010.02376.x. Epub 2010 Nov 24.
4
Low-molecular-weight heparin in patients with advanced cirrhosis.低分子肝素在晚期肝硬化患者中的应用。
Liver Int. 2011 Jan;31(1):75-82. doi: 10.1111/j.1478-3231.2010.02358.x. Epub 2010 Oct 20.
5
Pharmacokinetics of subcutaneous low molecular weight heparin (enoxaparin) in dogs.皮下注射低分子量肝素（依诺肝素）在犬体内的药代动力学
J Am Anim Hosp Assoc. 2009 Nov-Dec;45(6):261-7. doi: 10.5326/0450261.
6
Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.用于评估低分子肝素仿制药生物相似性的生物标志物与凝血试验：依诺肝素在健康受试者中的研究结果
J Clin Pharmacol. 2008 Oct;48(10):1189-96. doi: 10.1177/0091270008322911. Epub 2008 Aug 20.
7
[On the mechanism of gastrointestinal hemorrhage in liver cirrhosis].[关于肝硬化胃肠道出血的机制]
Vestn Khir Im I I Grek. 1968 Feb;100(2):50-2.
8
Use of thromboelastography to demonstrate persistent anticoagulation after stopping enoxaparin.使用血栓弹力图来证明停用依诺肝素后持续的抗凝作用。
Anaesthesia. 2007 Nov;62(11):1175-8. doi: 10.1111/j.1365-2044.2007.05225.x.
9
Routine laboratory monitoring for low-molecular-weight heparin prophylaxis in burns? Not so fast!烧伤患者使用低分子量肝素进行预防的常规实验室监测？别急着下结论！
J Burn Care Res. 2011 Jul-Aug;32(4):e155. doi: 10.1097/BCR.0b013e3182223f52.
10
Screening for esophageal varices among patients with cirrhosis of the liver.
Am J Gastroenterol. 2001 Oct;96(10):3039-40. doi: 10.1111/j.1572-0241.2001.04692.x.

引用本文的文献

1
Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management.肝硬化与凝血功能障碍：肝衰竭时止血变化的机制及其管理
Cureus. 2022 Apr 3;14(4):e23785. doi: 10.7759/cureus.23785. eCollection 2022 Apr.
2
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.肝病相关止血与血栓形成的概念与争议：第七届国际肝病凝血会议论文集
Thromb Haemost. 2018 Aug;118(8):1491-1506. doi: 10.1055/s-0038-1666861. Epub 2018 Jul 30.
3
Population pharmacokinetics of enoxaparin in early stage of paediatric liver transplantation.
儿童肝移植早期依诺肝素的群体药代动力学。
Br J Clin Pharmacol. 2018 Jun;84(6):1206-1214. doi: 10.1111/bcp.13543. Epub 2018 Mar 23.
4
Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis.凝血酶原转化减少和凝血酶失活降低解释了肝硬化中凝血酶生成的重新平衡。
PLoS One. 2017 May 4;12(5):e0177020. doi: 10.1371/journal.pone.0177020. eCollection 2017.
5
Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.非维生素K拮抗剂口服抗凝剂与传统抗凝剂的检测：止血检测的合理应用
Thromb J. 2014 Nov 4;12:24. doi: 10.1186/1477-9560-12-24. eCollection 2014.
6
Low molecular weight heparin in portal vein thrombosis of cirrhotic patients: only therapeutic purposes?低分子量肝素用于肝硬化患者门静脉血栓形成：仅用于治疗目的吗？
ScientificWorldJournal. 2014;2014:895839. doi: 10.1155/2014/895839. Epub 2014 Dec 29.
7
Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.肝硬化患者的深静脉血栓形成和肺栓塞：系统评价
World J Gastroenterol. 2014 May 21;20(19):5737-45. doi: 10.3748/wjg.v20.i19.5737.
8
Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis.肝硬化患者血浆中抗凝药物对凝血酶生成的体外抑制差异
PLoS One. 2014 Feb 4;9(2):e88390. doi: 10.1371/journal.pone.0088390. eCollection 2014.